Erratum: Proteomic analysis of nuclei isolated from cancer cell lines treated with indenoisoquinoline NSC 724998, a novel topoisomerase i inhibitor (Journal of Proteome Research (2010) 9 (4016-4027) (DOI: 10.1021/pr100194d));Proteomic analysis of nuclei isolated from cancer cell lines treated with indenoisoquinoline NSC 724998, a novel topoisomerase i inhibitor

Journal of Proteome Research

Volumn 9, Issue 8, 2010, Pages 4016-4027

  Han, Bingnan ^a   Stockwin, Luke H ^a   Hancock, Chad ^a   Yu, Sherry X ^a   Hollingshead, Melinda G ^b   Newton, Dianne L ^a  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

DNA damage; indenoisoquinoline; KAP1; nuclear proteome; proteasome; topoisomerase I; H2AX

Indexed keywords

ANTINEOPLASTIC AGENT; DNA TOPOISOMERASE INHIBITOR; ELECTRON TRANSFERRING FLAVOPROTEIN; HETEROGENOUS NUCLEAR RIBONUCLEOPROTEIN C LIKE 1; INDENOISOQUINOLINE; MRNA ASSOCIATED PROTEIN MRNP 41; NSC 724998; NUCLEAR PROTEIN; NUCLEAR PROTEIN HCC 1; NUCLEOLIN; NUCLEOPHOSMIN; PEROXIREDOXIN 1; PRE MRNA SPLICING FACTOR 19; PROTEASOME; PROTEOSOME SUBUNIT BETA TYPE 6 PRECURSOR; RIBONUCLEOPROTEIN; SERINE; SPLICING FACTOR ARGININE SERINE RICH 9; TRANSCRIPTION FACTOR; TRANSCRIPTION INTERMEDIARY FACTOR 1 BETA; U2 SMALL NUCLEAR RIBONUCLEOPROTEIN A; UBIQUITIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL LYSATE; CELL NUCLEUS; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; HUMAN; HUMAN CELL; IC 50; IMMUNOCYTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEOMICS; TUMOR XENOGRAFT; UPREGULATION; WESTERN BLOTTING;

EID: 77955443849     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr200128p     Document Type: Erratum

References (52)

1. Pommier, Y.; Cushman, M. The indenoisoquinoline noncamptothecin topoisomerase I inhibitors: update and perspectives Mol. Cancer Ther. 2009, 8, 1008-14
2. Pommier, Y. Topoisomerase I inhibitors: camptothecins and beyond Nat. Rev. Cancer 2006, 6 (10) 789-802
3. Paull, K. D.; Shoemaker, R. H.; Hodes, L.; Monks, A.; Scudiero, D. A.; Rubinstein, L.; Plowman, J.; Boyd, M. R. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm J. Natl. Cancer Inst. 1989, 81 (14) 1088-92
4. Kohlhagen, G.; Paull, K. D.; Cushman, M.; Nagafuji, P.; Pommier, Y. Protein-linked DNA strand breaks induced by NSC 314622, a novel noncamptothecin topoisomerase I poison Mol. Pharmacol. 1998, 54 (1) 50-8
5. Strumberg, D.; Pommier, Y.; Paull, K.; Jayaraman, M.; Nagafuji, P.; Cushman, M. Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons J. Med. Chem. 1999, 42 (3) 446-57
6. Cushman, M.; Jayaraman, M.; Vroman, J. A.; Fukunaga, A. K.; Fox, B. M.; Kohlhagen, G.; Strumberg, D.; Pommier, Y. Synthesis of new indeno[1,2-c] isoquinolines: cytotoxic non-camptothecin topoisomerase I inhibitors J. Med. Chem. 2000, 43 (20) 3688-98
7. Antony, S.; Jayaraman, M.; Laco, G.; Kohlhagen, G.; Kohn, K. W.; Cushman, M.; Pommier, Y. Differential induction of topoisomerase I-DNA cleavage complexes by the indenoisoquinoline MJ-III-65 (NSC 706744) and camptothecin: base sequence analysis and activity against camptothecin-resistant topoisomerases I Cancer Res. 2003, 63 (21) 7428-35
8. Antony, S.; Agama, K. K.; Miao, Z. H.; Takagi, K.; Wright, M. H.; Robles, A. I.; Varticovski, L.; Nagarajan, M.; Morrell, A.; Cushman, M.; Pommier, Y. Novel indenoisoquinolines NSC 725776 and NSC 724998 produce persistent topoisomerase I cleavage complexes and overcome multidrug resistance Cancer Res. 2007, 67 (21) 10397-405
9. Antony, S.; Kohlhagen, G.; Agama, K.; Jayaraman, M.; Cao, S.; Durrani, F. A.; Rustum, Y. M.; Cushman, M.; Pommier, Y. Cellular topoisomerase I inhibition and antiproliferative activity by MJ-III-65 (NSC 706744), an indenoisoquinoline topoisomerase I poison Mol. Pharmacol. 2005, 67 (2) 523-30
10. Bonner, W. M.; Redon, C. E.; Dickey, J. S.; Nakamura, A. J.; Sedelnikova, O. A.; Solier, S.; Pommier, Y. GammaH2AX and cancer Nat. Rev. Cancer 2008, 8 (12) 957-67
11. Teicher, B. A. Next generation topoisomerase I inhibitors: Rationale and biomarker strategies Biochem. Pharmacol. 2008, 75 (6) 1262-71
12. Yu, L. R.; Johnson, M. D.; Conrads, T. P.; Smith, R. D.; Morrison, R. S.; Veenstra, T. D. Proteome analysis of camptothecin-treated cortical neurons using isotope-coded affinity tags Electrophoresis 2002, 23 (11) 1591-8
13. Wang, Y.; Dai, Z.; Sadee, W.; Hancock, W. S. A pharmacoproteomics study of the cancer cell line EKVX using capillary-LC/MS/MS Mol. Pharm. 2006, 3 (5) 566-78
14. Yu, Y.; Wang, L. S.; Shen, S. M.; Xia, L.; Zhang, L.; Zhu, Y. S.; Chen, G. Q. Subcellular proteome analysis of camptothecin analogue NSC606985-treated acute myeloid leukemic cells J. Proteome Res. 2007, 6 (9) 3808-18
15. Desai, S. D.; Li, T. K.; Rodriguez-Bauman, A.; Rubin, E. H.; Liu, L. F. Ubiquitin/26S proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells Cancer Res. 2001, 61 (15) 5926-32
16. Desai, S. D.; Liu, L. F.; Vazquez-Abad, D.; D'Arpa, P. Ubiquitin-dependent destruction of topoisomerase I is stimulated by the antitumor drug camptothecin J. Biol. Chem. 1997, 272 (39) 24159-64
17. von Mikecz, A. The nuclear ubiquitin-proteasome system J. Cell Sci. 2006, 119 (Pt 10) 1977-84
18. Yajima, H.; Lee, K. J.; Zhang, S.; Kobayashi, J.; Chen, B. P. DNA double-strand break formation upon UV-induced replication stress activates ATM and DNA-PKcs kinases J. Mol. Biol. 2009, 385 (3) 800-10
19. Liu, G.; Chen, X. The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis Oncogene 2002, 21 (47) 7195-204
20. Okumura, H.; Ishii, H.; Pichiorri, F.; Croce, C. M.; Mori, M.; Huebner, K. Fragile gene product, Fhit, in oxidative and replicative stress responses Cancer Sci. 2009, 100 (7) 1145-50
21. Angell, J. E.; Lindner, D. J.; Shapiro, P. S.; Hofmann, E. R.; Kalvakolanu, D. V. Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon-beta and retinoic acid combination, using a genetic approach J. Biol. Chem. 2000, 275 (43) 33416-26
22. Jung, H.; Seong, H. A.; Ha, H. Direct interaction between NM23-H1 and macrophage migration inhibitory factor (MIF) is critical for alleviation of MIF-mediated suppression of p53 activity J. Biol. Chem. 2008, 283 (47) 32669-79
23. Choi, K. J.; Piao, Y. J.; Lim, M. J.; Kim, J. H.; Ha, J.; Choe, W.; Kim, S. S. Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death Cancer Res. 2007, 67 (8) 3654-62
24. Sirover, M. A. New nuclear functions of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in mammalian cells J. Cell. Biochem. 2005, 95 (1) 45-52
25. Lee, S. M.; Kim, J. H.; Cho, E. J.; Youn, H. D. A nucleocytoplasmic malate dehydrogenase regulates p53 transcriptional activity in response to metabolic stress Cell Death Differ. 2009, 16 (5) 738-48
26. Yang, C.; Sudderth, J.; Dang, T.; Bachoo, R. G.; McDonald, J. G.; DeBerardinis, R. J. Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling Cancer Res. 2009, 69 (20) 7986-93
27. Stockwin, L. H.; Bumke, M. A.; Yu, S. X.; Webb, S. P.; Collins, J. R.; Hollingshead, M. G.; Newton, D. L. Proteomic analysis identifies oxidative stress induction by adaphostin Clin. Cancer Res. 2007, 13 (12) 3667-81
28. Valencia, C. A.; Ju, W.; Liu, R. Matrin 3 is a Ca2+/calmodulin-binding protein cleaved by caspases Biochem. Biophys. Res. Commun. 2007, 361 (2) 281-6
29. Buzza, M. S.; Zamurs, L.; Sun, J.; Bird, C. H.; Smith, A. I.; Trapani, J. A.; Froelich, C. J.; Nice, E. C.; Bird, P. I. Extracellular matrix remodeling by human granzyme B via cleavage of vitronectin, fibronectin, and laminin J. Biol. Chem. 2005, 280 (25) 23549-58
30. Chua, B. T.; Volbracht, C.; Tan, K. O.; Li, R.; Yu, V. C.; Li, P. Mitochondrial translocation of cofilin is an early step in apoptosis induction Nat. Cell Biol. 2003, 5 (12) 1083-9
31. Adams, J. The proteasome: structure, function, and role in the cell Cancer Treat. Rev. 2003, 29, 3-9
32. Vlachostergios, P. J.; Patrikidou, A.; Daliani, D. D.; Papandreou, C. N. The Ubiquitin-Proteasome System in cancer, a major player in DNA Repair. Part 1: Post-translational regulation J. Cell. Mol. Med. 2009, 13 (9b) 3006-18
33. Vlachostergios, P. J.; Patrikidou, A.; Daliani, D. D.; Papandreou, C. N. The Ubiquitin-Proteasome System in cancer, a major player in DNA Repair. Part 2: Transcriptional regulation J. Cell. Mol. Med. 2009, 13 (9b) 3019-31
34. Motegi, A.; Murakawa, Y.; Takeda, S. The vital link between the ubiquitin-proteasome pathway and DNA repair: impact on cancer therapy Cancer Lett. 2009, 283 (1) 1-9
35. Wei, N.; Serino, G.; Deng, X. W. The COP9 signalosome: more than a protease Trends Biochem. Sci. 2008, 33 (12) 592-600
36. Vassin, V. M.; Wold, M. S.; Borowiec, J. A. Replication protein A (RPA) phosphorylation prevents RPA association with replication centers Mol. Cell. Biol. 2004, 24 (5) 1930-43
37. Stoimenov, I.; Helleday, T. PCNA on the crossroad of cancer Biochem. Soc. Trans. 2009, 37 (Pt 3) 605-13
38. Vasseur, S.; Afzal, S.; Tardivel-Lacombe, J.; Park, D. S.; Iovanna, J. L.; Mak, T. W. DJ-1/PARK7 is an important mediator of hypoxia-induced cellular responses Proc. Natl. Acad. Sci. U.S.A. 2009, 106 (4) 1111-6
39. Abe, Y.; Yoon, S. O.; Kubota, K.; Mendoza, M. C.; Gygi, S. P.; Blenis, J. p90 ribosomal S6 kinase and p70 ribosomal S6 kinase link phosphorylation of the eukaryotic chaperonin containing TCP-1 to growth factor, insulin, and nutrient signaling J. Biol. Chem. 2009, 284 (22) 14939-48
40. Meder, V. S.; Boeglin, M.; de Murcia, G.; Schreiber, V. PARP-1 and PARP-2 interact with nucleophosmin/B23 and accumulate in transcriptionally active nucleoli J. Cell Sci. 2005, 118 (Pt 1) 211-22
41. Lu, X.; Legerski, R. J. The Prp19/Pso4 core complex undergoes ubiquitylation and structural alterations in response to DNA damage Biochem. Biophys. Res. Commun. 2007, 354 (4) 968-74
42. Srivastava, M.; Pollard, H. B. Molecular dissection of nucleolin's role in growth and cell proliferation: new insights FASEB J. 1999, 13 (14) 1911-22
43. Daniely, Y.; Dimitrova, D. D.; Borowiec, J. A. Stress-dependent nucleolin mobilization mediated by p53-nucleolin complex formation Mol. Cell. Biol. 2002, 22 (16) 6014-22
44. Friedman, J. R.; Fredericks, W. J.; Jensen, D. E.; Speicher, D. W.; Huang, X. P.; Neilson, E. G.; Rauscher, F. J. 3rd, KAP-1, a novel corepressor for the highly conserved KRAB repression domain Genes Dev. 1996, 10 (16) 2067-78
45. Li, X.; Lee, Y. K.; Jeng, J. C.; Yen, Y.; Schultz, D. C.; Shih, H. M.; Ann, D. K. Role for KAP1 serine 824 phosphorylation and sumoylation/ desumoylation switch in regulating KAP1-mediated transcriptional repression J. Biol. Chem. 2007, 282 (50) 36177-89
46. He, Y.; Smith, R. Nuclear functions of heterogeneous nuclear ribonucleoproteins A/B Cell. Mol. Life Sci. 2009, 66 (7) 1239-56
47. Haley, B.; Paunesku, T.; Protic, M.; Woloschak, G. E. Response of heterogeneous ribonuclear proteins (hnRNP) to ionising radiation and their involvement in DNA damage repair Int. J. Radiat. Biol. 2009, 85 (8) 643-55
48. Ghavidel, A.; Kislinger, T.; Pogoutse, O.; Sopko, R.; Jurisica, I.; Emili, A. Impaired tRNA nuclear export links DNA damage and cell-cycle checkpoint Cell 2007, 131 (5) 915-26
49. Munoz, M. J.; Perez Santangelo, M. S.; Paronetto, M. P.; de la Mata, M.; Pelisch, F.; Boireau, S.; Glover-Cutter, K.; Ben-Dov, C.; Blaustein, M.; Lozano, J. J.; Bird, G.; Bentley, D.; Bertrand, E.; Kornblihtt, A. R. DNA damage regulates alternative splicing through inhibition of RNA polymerase II elongation Cell 2009, 137 (4) 708-20
50. Fukuda, S.; Pelus, L. M. Growth inhibitory effect of Hcc-1/CIP29 is associated with induction of apoptosis, not just with G2/M arrest Cell. Mol. Life Sci. 2005, 62 (13) 1526-7
51. Egler, R. A.; Fernandes, E.; Rothermund, K.; Sereika, S.; de Souza-Pinto, N.; Jaruga, P.; Dizdaroglu, M.; Prochownik, E. V. Regulation of reactive oxygen species, DNA damage, and c-Myc function by peroxiredoxin 1 Oncogene 2005, 24 (54) 8038-50
52. Unwin, R. D.; Griffiths, J. R.; Whetton, A. D. A sensitive mass spectrometric method for hypothesis-driven detection of peptide post-translational modifications: multiple reaction monitoring-initiated detection and sequencing (MIDAS) Nat. Protoc. 2009, 4 (6) 870-7